Go here to see the original: Vidac Pharma presents high efficacy in multiple solid tumor models for its next-generation cancer drug candidate and synergy with standard-of-care...
Go here to see the original: Vidac Pharma presents high efficacy in multiple solid tumor models for its next-generation cancer drug candidate and synergy with standard-of-care...
Here is the original post: New collaboration between Boehringer Ingelheim and Sleip leverages AI-technology to help detect lameness in horses
Read more: BioCryst Launches ORLADEYO® (berotralstat) in Italy
Read more: Orion to investigate the possible outsourcing of its pharmaceutical production in Kuopio, Finland
See original here: Medigene to Present at Upcoming Conferences
Follow this link: argenx Announces FDA Acceptance of Supplemental Biologics License Application with Priority Review for VYVGART Hytrulo in Chronic Inflammatory...
Read this article: Opthea Appoints Arshad M. Khanani, MD, MA, FASRS, as Chief Medical Advisor
Read the original post: Zealand Pharma conference call on February 27 at 2pm CET (8am ET) to present full year 2023 financial results
View post: Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients with...
Follow this link: Press Release: Japan first in the world to approve Dupixent® for chronic spontaneous urticaria (CSU)
Recent Comments